Stuart Lutzker

4.1k total citations · 1 hit paper
30 papers, 3.4k citations indexed

About

Stuart Lutzker is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Stuart Lutzker has authored 30 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Stuart Lutzker's work include T-cell and B-cell Immunology (12 papers), Cancer-related Molecular Pathways (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Stuart Lutzker is often cited by papers focused on T-cell and B-cell Immunology (12 papers), Cancer-related Molecular Pathways (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Stuart Lutzker collaborates with scholars based in United States, Australia and Germany. Stuart Lutzker's co-authors include Frederick W. Alt, Arnold J. Levine, Paul B. Rothman, Robert L. Coffman, George D. Yancopoulos, Nicoleta C. Arva, Elisabeth E. Bond, Shih-Jen Hwang, Jill Bargonetti and Linwah Yip and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Stuart Lutzker

29 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans

2004 1.0k citations Gareth L. Bond, Wenwei Hu et al. Cell profile →

Peers

Countries citing papers authored by Stuart Lutzker

Since Specialization

Citations

This map shows the geographic impact of Stuart Lutzker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Lutzker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Lutzker more than expected).

Fields of papers citing papers by Stuart Lutzker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Lutzker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Lutzker. The network helps show where Stuart Lutzker may publish in the future.

Co-authorship network of co-authors of Stuart Lutzker

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Lutzker. A scholar is included among the top collaborators of Stuart Lutzker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Lutzker. Stuart Lutzker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 1964: Furmonertinib is a brain-penetrant EGFR TKI highly active in uncommon EGFR mutations, including PACC and exon 20 insertions 2024 ·Cancer Research ·Monique B. Nilsson, Zineb Mounir, Luna Musib, Junqin He, Xiaoxing Yu, Qing Li, (unknown), John V. Heymach, Jerry Y. Hsu, Stuart Lutzker, Xiuning Le, Marcin Kowanetz	0
2	Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer 2010 ·Journal of Clinical Oncology ·Ian E. Krop, Muralidhar Beeram, Shanu Modi, Suzanne F. Jones, Scott N. Holden, Wei Yu, Sandhya Girish, Jay Tibbitts, Joo‐Hee Yi, Mark X. Sliwkowski, Fred Jacobson, Stuart Lutzker, Howard A. Burris	437
3	Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer 2007 ·Clinical Cancer Research ·Roy S. Herbst, Angela M. Davies, Ronald B. Natale, Thao P. Dang, Joan H. Schiller, Linda L. Garland, Vincent A. Miller, David S. Mendelson, Annick D. Van den Abbeele, Yulia Melenevsky, D.J. de Vries, David A. Eberhard, Benjamin Lyons, Stuart Lutzker, Bruce E. Johnson	79
4	A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans breakdown → 2004 ·Cell ·Gareth L. Bond, Wenwei Hu, Elisabeth E. Bond, Harlan Robins, Stuart Lutzker, Nicoleta C. Arva, Jill Bargonetti, Frank Bartel, Helge Täubert, Peter Wuerl, Kenan Onel, Linwah Yip, Shih-Jen Hwang, Louise C. Strong, Guillermina Lozano, Arnold J. Levine	1026
5	Topors Functions as an E3 Ubiquitin Ligase with Specific E2 Enzymes and Ubiquitinates p53 2004 ·Journal of Biological Chemistry ·(unknown), (unknown), Pooja Pungaliya, (unknown), Zeshaan A. Rasheed, James E. Brownell, Leroy F. Liu, Stuart Lutzker, Ahamed Saleem, Eric H. Rubin	152
6	Augmentation of apoptosis by the combination of bleomycin with trifluoperazine in the presence of mutant p53 2002 ·PubMed ·Gregory F. Sullivan, (unknown), Eileen White, Stuart Lutzker, William N. Hait	16
7	A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells 2001 ·Oncogene ·Stuart Lutzker, Robin Mathew, (unknown)	34
8	Testicular germ cell tumors: molecular understanding and clinical implications 1998 ·Molecular Medicine Today ·Stuart Lutzker, Nicola Barnard	19
9	P53 tumour suppressor gene and germ cell neoplasia 1998 ·Apmis ·Stuart Lutzker	49
10	A functionally inactive p53 protein interatocarcinoma cells is activated by either DNA damage or cellular differentiation 1996 ·Nature Medicine ·Stuart Lutzker, Arnold J. Levine	169
11	Apoptosis and Cancer Chemotherapy 1996 ·Cancer treatment and research ·Stuart Lutzker, Arnold J. Levine	28
12	Structure and expression of germline immunoglobulin γ³ heavy chain gene transcripts: implications for mitogen and lymphokine directed class-switching 1990 ·International Immunology ·Paul B. Rothman, Stuart Lutzker, Beverly J. Gorham, Valerie Stewart, Robert L. Coffman, Frederick W. Alt	65
13	Mitogen plus interleukin 4 induction of C epsilon transcripts in B lymphoid cells. 1988 ·The Journal of Experimental Medicine ·Paul B. Rothman, Stuart Lutzker, W D Cook, Robert L. Coffman, Frederick W. Alt	178
14	Mitogen- and IL-4-regulated expression of germ-line Ig γ2b transcripts: Evidence for directed heavy chain class switching 1988 ·Cell ·Stuart Lutzker, Paul B. Rothman, Roberta R. Pollock, Robert L. Coffman, Frederick W. Alt	242
15	Control of Recombination Events During Lymphocyte Differentiation: Heavy Chain Variable Region Gene Assembly and Heavy Chain Class Switchinga 1988 ·Annals of the New York Academy of Sciences ·Frederick W. Alt, Pierre Ferrier, Barbara A. Malynn, Stuart Lutzker, Paul B. Rothman, Jeffrey E. Berman, Keith E. Blackwell, Scott Mellis, Roberta R. Pollock, Andrew J. Furley, Gary Rathbun, George D. Yancopoulos, Ton Logtenberg, Maureen A. Morrow, Wendy D. Cook, (unknown), Heikyung Suh	8
16	Structure and Expression of Germ Line Immunoglobulin γ2b Transcripts 1988 ·Molecular and Cellular Biology ·Stuart Lutzker, Frederick W. Alt	36
17	Structure and expression of germ line immunoglobulin gamma 2b transcripts. 1988 ·Molecular and Cellular Biology ·Stuart Lutzker, Frederick W. Alt	116
18	Secondary genomic rearrangement events in pre-B cells: VHDJH replacement by a LINE-1 sequence and directed class switching. 1986 ·The EMBO Journal ·George D. Yancopoulos, Ronald A. DePinho, Kathy A. Zimmerman, Stuart Lutzker, Naomi Rosenberg, Frederick W. Alt	190
19	Molecular Basis of Heavy-Chain Class Switching and Switch Region Deletion in an Abelson Virus-Transformed Cell Line 1984 ·Molecular and Cellular Biology ·Ronald A. DePinho, Kelly Kruger, Nancy C. Andrews, Stuart Lutzker, David Baltimore, Frederick W. Alt	17
20	Radiological signs of acute pancreatitis. 1976 ·PubMed ·Balthazar Ej, Stuart Lutzker	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact